Author:
Edition: 2013
Binding: Hardcover
ISBN: 1461454557
Download Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications (Cancer Drug Discovery and Development) from rapidshare, mediafire, 4shared. Search and find a lot of medical books in many category availabe for free download. Antibody-Drug Conjugates and Immunotoxins medical books pdf for free.
Edition: 2013
Binding: Hardcover
ISBN: 1461454557
Download Antibody-Drug Conjugates and Immunotoxins: From Pre-Clinical Development to Therapeutic Applications (Cancer Drug Discovery and Development) from rapidshare, mediafire, 4shared. Search and find a lot of medical books in many category availabe for free download. Antibody-Drug Conjugates and Immunotoxins medical books pdf for free.
Related books
Therapeutic antibody engineering: Current and future advances driving the strongest growth area in the pharmaceutical industry (Woodhead Publishing Series in Biomedicine)
The field of antibody engineering has become a vital and integral part of making new, improved next generation therapeutic monoclonal antibodies, of which there are currently more than 300 in clinical trials across several therapeutic areas.
T
Therapeutic Monoclonal Antibodies: From Bench to Clinic
70-chapter authoritative reference that covers therapeutic monoclonal antibody discovery, development, and clinical applications while incorporating principles, experimental data, and methodologies.AFirst book to address the discovery and developmen
Bioconjugate Techniques, Second Edition
Bioconjugate Techniques, 2e provides highly detailed information on the chemistry, reagent systems, and practical applications for creating labeled or conjugate molecules. It also describes dozens of reactions with details on hundreds of commercially
Cellular and Molecular Immunology: with STUDENT CONSULT Online Access, 7e (Abbas, Cellular and Molecular Immunology)
Cellular and Molecular Immunology takes a comprehensive yet straightforward approach to the latest developments in this active and fast-changing field. Drs. Abul K. Abbas, Andrew H. Lichtman, and Shiv Pillai present sweeping updates in this new editi
Bispecific Antibodies
The concept of using bispecific antibodies for cancer therapy by retargeting immune effector cells was developed several years ago. Initial clinical studies were rather disappointing mainly due to low efficacy, severe side effects and the immunogenic
Tidak ada komentar:
Posting Komentar